Olshan Client Pharmacyclics Enjoys Significant Growth in 2013

The Wall Street Journal reported that small-company stocks have produced large returns in 2013 so far, particularly in recent weeks, according to the Russell 2000 index. One of the companies enjoying this surge of investor interest is Olshan client Pharmacyclics Inc., which has gained 81% this year. Olshan represents Pharmacyclics in connection with its corporate and securities matters.